Biodesix Stock Alpha and Beta Analysis
| BDSX Stock | USD 1.36 0.08 5.56% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biodesix. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biodesix over a specified time horizon. Remember, high Biodesix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biodesix's market risk premium analysis include:
Beta (0.01) | Alpha (0.37) | Risk 4.39 | Sharpe Ratio (0.08) | Expected Return (0.37) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biodesix |
Biodesix Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biodesix market risk premium is the additional return an investor will receive from holding Biodesix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biodesix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biodesix's performance over market.| α | -0.37 | β | -0.0053 |
Biodesix expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biodesix's Buy-and-hold return. Our buy-and-hold chart shows how Biodesix performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biodesix Market Price Analysis
Market price analysis indicators help investors to evaluate how Biodesix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biodesix shares will generate the highest return on investment. By understating and applying Biodesix stock market price indicators, traders can identify Biodesix position entry and exit signals to maximize returns.
Biodesix Return and Market Media
The median price of Biodesix for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 is 1.65 with a coefficient of variation of 12.22. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 1.6, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 327 shares by Robin Cowie of Biodesix subject to Rule 16b-3 | 10/11/2024 |
2 | Acquisition by Scott Hutton of 180926 shares of Biodesix at 1.46 subject to Rule 16b-3 | 10/22/2024 |
3 | Acquisition by Vazquez Chris of tradable shares of Biodesix subject to Rule 16b-3 | 10/25/2024 |
4 | Acquisition by Kennedy Lawrence T. Jr of 51200 shares of Biodesix at 1.365 subject to Rule 16b-3 | 11/05/2024 |
5 | Biodesix director Jack Schuler buys 136k in stock | 11/06/2024 |
6 | Disposition of 3156 shares by Robin Cowie of Biodesix subject to Rule 16b-3 | 11/08/2024 |
7 | Disposition of 500 shares by Robin Cowie of Biodesix at 1.3909 subject to Rule 16b-3 | 11/11/2024 |
8 | Disposition of 471 shares by Robin Cowie of Biodesix at 1.4008 subject to Rule 16b-3 | 11/12/2024 |
9 | Biodesix CEO Scott Hutton sells 5,219 in stock | 11/13/2024 |
10 | Disposition of tradable shares by Gary Pestano of Biodesix subject to Rule 16b-3 | 11/18/2024 |
11 | Acquisition by Schuler Jack W of 200000 shares of Biodesix at 1.17 subject to Rule 16b-3 | 11/20/2024 |
12 | With A 26 percent Price Drop For Biodesix, Inc. Youll Still Get What You Pay For | 11/21/2024 |
13 | Biodesix director Jack Schuler buys 122,840 in stock | 11/22/2024 |
14 | Disposition of 2781 shares by Scott Hutton of Biodesix at 1.601 subject to Rule 16b-3 | 11/25/2024 |
About Biodesix Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biodesix or other stocks. Alpha measures the amount that position in Biodesix has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 18.36 | 8.4 | 4.44 | 5.62 | Days Of Inventory On Hand | 34.68 | 36.1 | 39.28 | 49.36 |
Biodesix Upcoming Company Events
As portrayed in its financial statements, the presentation of Biodesix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biodesix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biodesix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biodesix. Please utilize our Beneish M Score to check the likelihood of Biodesix's management manipulating its earnings.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Biodesix
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.